Malic acid supplement with immunotherapy for solid tumors
Part of Cancer, Immune system & allergy clinical trials.
This study tests whether taking malic acid (a natural supplement) along with standard immunotherapy can help people with solid tumors like colorectal, lung, or melanoma cancer. The goal is to see if the supplement makes the immunotherapy work better or cause fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to have a solid tumor like colorectal cancer, lung cancer, or melanoma.
- You should have at least one tumor that can be measured on a scan.
- You must be currently receiving immunotherapy.
- Your organs (like kidneys, liver, and blood counts) need to be working well enough, based on blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational treatment called LM303 for people with advanced solid tumors like melanoma, lung cancer, or cervical cancer. It uses your own immune cells (called TILs) to fight the cancer, so you need a tumor large enough for cells to be collected.
This trial tests whether a special diet low in certain amino acids (building blocks of protein), combined with an immune-boosting antibody drug, can safely shrink stage III melanoma that has spread to lymph nodes. The goal is to see if this combination works better than standard treatment.
This study tests additional therapies given alongside standard immunotherapy for advanced melanoma or liver cancer. The goal is to see if adding these treatments can make the immunotherapy work better.
This study tests whether a simple sugar syrup called lactulose can improve gut health and make immunotherapy work better for certain cancers. Lactulose is taken by mouth along with your regular immunotherapy.
This study tests whether adding alpha-lipoic acid (an antioxidant) to standard chemotherapy or immunotherapy can help people with advanced non-small cell lung cancer. It aims to see if it improves treatment outcomes or reduces side effects.
This early-phase trial tests a new type of cancer vaccine designed to help your immune system attack tumors. It is for people with advanced solid tumors who have run out of standard options.
Hear when a new Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.